A combination of genetic tests for a “very complex” blood cancer could accurately predict if the disease is likely to return within 18 months of treatment,...
A combination of genetic tests for a “very complex” blood cancer could accurately predict if the disease is likely to return within 18 months of treatment,...
More than 15,000 women a year who have breast cancer in the UK would benefit from tests that analyse DNA for changes or mutations, a study...
Sodiq Ojuroungbe A leading healthcare technology company, DemyHealth, has announced the expansion of its DNA testing capabilities beyond paternity-related services, positioning itself as one of the...
Breast cancer is the most common cancer in women worldwide. In sub-Saharan Africa, it is a leading cause of cancer-related deaths among women. Risk factors for...